1012 related articles for article (PubMed ID: 22414388)
1. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
2. New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Nanomedicine; 2012; 7():5475-89. PubMed ID: 23093903
[TBL] [Abstract][Full Text] [Related]
3. New respirable and fast dissolving itraconazole dry powder composition for the treatment of invasive pulmonary aspergillosis.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Pharm Res; 2012 Oct; 29(10):2845-59. PubMed ID: 22644590
[TBL] [Abstract][Full Text] [Related]
4. Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations.
Karashima M; Sano N; Yamamoto S; Arai Y; Yamamoto K; Amano N; Ikeda Y
Eur J Pharm Biopharm; 2017 Jun; 115():65-72. PubMed ID: 28223260
[TBL] [Abstract][Full Text] [Related]
5. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.
Davis MT; Potter CB; Mohammadpour M; Albadarin AB; Walker GM
Int J Pharm; 2017 Mar; 519(1-2):365-372. PubMed ID: 28131850
[TBL] [Abstract][Full Text] [Related]
6. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention.
Duret C; Merlos R; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Eur J Pharm Biopharm; 2014 Jan; 86(1):46-54. PubMed ID: 23523546
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
Parikh T; Sandhu HK; Talele TT; Serajuddin AT
Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
[TBL] [Abstract][Full Text] [Related]
9. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
Sun W; Ni R; Zhang X; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
[TBL] [Abstract][Full Text] [Related]
10. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
[TBL] [Abstract][Full Text] [Related]
11. Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance.
Van Eerdenbrugh B; Van Speybroeck M; Mols R; Houthoofd K; Martens JA; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G
Eur J Pharm Sci; 2009 Oct; 38(3):270-8. PubMed ID: 19686846
[TBL] [Abstract][Full Text] [Related]
12. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study.
Janssens S; Nagels S; Armas HN; D'Autry W; Van Schepdael A; Van den Mooter G
Eur J Pharm Biopharm; 2008 May; 69(1):158-66. PubMed ID: 18164929
[TBL] [Abstract][Full Text] [Related]
13. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
[TBL] [Abstract][Full Text] [Related]
14. Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.
Moneghini M; De Zordi N; Solinas D; Macchiavelli S; Princivalle F
Future Med Chem; 2010 Feb; 2(2):237-46. PubMed ID: 21426191
[TBL] [Abstract][Full Text] [Related]
15. NanoCluster Itraconazole Formulations Provide a Potential Engineered Drug Particle Approach to Generate Effective Dry Powder Aerosols.
Pornputtapitak W; El-Gendy N; Berkland C
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):341-52. PubMed ID: 25679514
[TBL] [Abstract][Full Text] [Related]
16. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.
Yang W; Tam J; Miller DA; Zhou J; McConville JT; Johnston KP; Williams RO
Int J Pharm; 2008 Sep; 361(1-2):177-88. PubMed ID: 18556158
[TBL] [Abstract][Full Text] [Related]
17. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
Mou D; Chen H; Wan J; Xu H; Yang X
Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
[TBL] [Abstract][Full Text] [Related]
18. Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.
Lang B; Liu S; McGinity JW; Williams RO
Drug Dev Ind Pharm; 2016; 42(3):429-45. PubMed ID: 26355819
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
[TBL] [Abstract][Full Text] [Related]
20. Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).
Brough C; Miller DA; Keen JM; Kucera SA; Lubda D; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):167-79. PubMed ID: 26637232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
